In normal enterocytes, the transcriptional activity of the β-promoter is potently inhibited by the transcription factor forkhead box D3 (FOXD3); in colorectal cancer cells, FOXD3 is epigenetically silenced by methylation, allowing the expression of DCLK1-S [430]. The gene discussed is FOXD3; the disease is colorectal cancer.